Sustainability
As one of the leading partners in the biopharmaceutical industry, we are committed to contributing to a future, where more people have access to better medicine.
With this, we directly address the UN sustainability goal "good health and well-being".
Top Stories
The Sartorius Annual Report contains a Non-Financial Group Statement as a separate chapter in the Combined Group Management Report, which is subject to audit within the scope of a limited assurance engagement. The Independent Auditors’ Report is published in the Annual Report.
As of 2018, Sartorius Stedim Biotech is exempt from the obligation of providing a Non-Financial Group Statement. However, we provide our full SSB sustainability disclosure in the GRI Report for Sartorius Stedium Biotech.
Sartorius’ sustainability performance is regularly assessed by ESG rating agencies. The results are incorporated into our activities for continuous improvement.
In addition, Sartorius AG is listed in the DAX ESG 50 sustainability index of Deutsche Börse. The index lists the leading 50 companies based on ESG (Environmental, Social, Governance) performance, market capitalization and sales revenue.